Addressing ART Safety and Tolerability in Transgender Individuals
Listen as 2 experts discuss approaches to ART safety and tolerability in transgender individuals, including clinically relevant drug interactions and additional considerations such as gender-affirming care.
Decera Clinical Education Infectious Disease Podcast · Jill Blumenthal MD MAS, Jennifer Cocohoba PharmD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:
- Strategies on how to approach different ARV-related toxicities
- Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)
- Clinically relevant drug–drug interactions related to HIV and gender-affirming care
- Methods to reduce barriers to ART adherence
Faculty:
Jill Blumenthal, MD, MAS
Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California
Jennifer Cocohoba, PharmD
Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Women’s HIV Program
University of California San Francisco Medical Center
San Francisco, California
Link to full program:
https://bit.ly/3PM3nYe
Follow along with the slides at:
https://bit.ly/3NpAYI1
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.